Pay AstraZeneca royalties on total sales of ovarian cancer drug Zejula: UK Court orders GSK's Tesaro Ruchika Sharma6 April 2023 10:00 AM ISTUK: A UK court on Wednesday ordered GSK's Tesaro to pay rival AstraZeneca royalties on total sales of ovarian cancer drug Zejula, in a win for the...
British drugmaker GSK sees USD 500 million peak sales for yeast infection pill licensed from Scynexis Ruchika Sharma2 April 2023 4:00 PM ISTLondon: British drugmaker GSK sees peak sales of more than $500 million for a drug to treat yeast infections that it licensed from US biotech company...
Johnson and Johson to discontinue late-stage study of RSV vaccine Ruchika Sharma31 March 2023 4:00 PM ISTPfizer and GSK are running a tight race to tap into the RSV vaccine market, which is estimated to be more than $5 billion and could exceed $10 billion...
Cipla, Aurobindo, Viatris in licensing pact with MPP to produce generic versions of ViiV Healthcare HIV drug Ruchika Sharma31 March 2023 3:09 PM ISTAurobindo and Viatris will manufacture in India; Cipla will manufacture in India and has plans to manufacture in South Africa as well.
GSK loses bid to keep experts out of upcoming Zantac trial Ruchika Sharma25 March 2023 12:30 PM ISTGSK said in a statement it disagreed with the ruling and would defend the case at trial.
CDSCO panel grants GSK's proposal for Updation of Package Insert of Infanrix Hexa Vaccine Dr. Divya Colin22 March 2023 6:00 PM ISTNew Delhi: Pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Glenmark Pharma gets final USFDA nod for Schizophrenia drug Prochlorperazine Maleate Ruchika Sharma21 March 2023 4:00 PM ISTMumbai: Glenmark Pharmaceuticals Ltd. has announced that the company has received final approval from the United States Food & Drug Administration...
GSK declares positive pivotal phase III data for 5-in-1 Meningococcal ABCWY vaccine Ruchika Sharma15 March 2023 5:30 PM ISTLondon: GSK plc has announced positive headline results from the phase III trial (NCT04502693) evaluating the safety, tolerability, and immunogenicity...
GSK, Pfizer ready to launch RSV vaccines for older adults in US Ruchika Sharma12 March 2023 2:30 PM ISTRSV is a leading cause of pneumonia in infants and the elderly, and decades of research have finally resulted in the two successful vaccines Pfizer...
GSK spinoff Haleon has no deals on immediate horizon Ruchika Sharma5 March 2023 10:00 AM ISTLondon: Consumer healthcare group Haleon's Chief Executive Brian McNamara said on Thursday he does not expect to announce any acquisitions or...
GSK gets full USFDA nod for Jemperli to treat recurrent or advanced mismatch repair deficient endometrial cancer Ruchika Sharma11 Feb 2023 11:30 AM ISTJemperli is a programmed death receptor-1 (PD-1)-blocking antibody that binds to the PD-1 receptor and blocks its interaction with the PD-1 ligands...
GlaxoSmithKline Pharma reports 9.45 percent rise in consolidated net profit at Rs 164.56 crore in Q3 Ruchika Sharma8 Feb 2023 1:15 PM ISTNew Delhi: GlaxoSmithKline Pharmaceuticals Ltd on Tuesday reported a 9.45 percent rise in consolidated net profit at Rs 164.56 crore in the third...
